Your browser doesn't support javascript.
loading
Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial.
Ryan, C; Guenther, L; Foley, P; Weisman, J; Burge, R T; Gallo, G; See, K; McKean-Matthews, M; Bertram, C C; Merola, J F.
Affiliation
  • Ryan C; Charles Institute of Dermatology, University College, Dublin, Ireland.
  • Guenther L; Institute of Dermatologists, Dublin, Ireland.
  • Foley P; Guenther Dermatology Research Centre, London, ON, Canada.
  • Weisman J; Skin Health Institute, Melbourne, VIC, Australia.
  • Burge RT; Medical Dermatology Specialists, Atlanta, GA, USA.
  • Gallo G; Eli Lilly and Company, Indianapolis, IN, USA.
  • See K; University of Cincinnati, Cincinnati, OH, USA.
  • McKean-Matthews M; Eli Lilly and Company, Indianapolis, IN, USA.
  • Bertram CC; Eli Lilly and Company, Indianapolis, IN, USA.
  • Merola JF; Syneos Health, Raleigh, NC, USA.
J Eur Acad Dermatol Venereol ; 36(4): e277-e279, 2022 Apr.
Article in En | MEDLINE | ID: mdl-34812561

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Dermatologic Agents Type of study: Clinical_trials / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Ireland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Dermatologic Agents Type of study: Clinical_trials / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Ireland Country of publication: United kingdom